Kathryn C. Zoon

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathryn C. Zoon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. Director Common Stock 71.8K $637K $8.87 15 Aug 2025 Direct
Emergent BioSolutions Inc. Director Stock Option (Right to Buy) 41.6K 30 Apr 2025 Direct

Insider Reports Filed by Kathryn C. Zoon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EBS Emergent BioSolutions Inc. 15 Aug 2025 1 -$62.9K 4 Director 18 Aug 2025, 16:33
EBS Emergent BioSolutions Inc. 30 Apr 2025 2 $0 4 Director 02 May 2025, 20:31
EBS Emergent BioSolutions Inc. 12 Mar 2025 1 -$57.3K 4 Director 12 Mar 2025, 18:13
EBS Emergent BioSolutions Inc. 04 Jun 2024 1 -$61.1K 4 Director 06 Jun 2024, 16:16
EBS Emergent BioSolutions Inc. 29 May 2024 1 -$8.44K 4 Director 31 May 2024, 15:02
EBS Emergent BioSolutions Inc. 23 May 2024 2 $0 4 Director 28 May 2024, 21:14
EBS Emergent BioSolutions Inc. 21 May 2024 1 -$6.29K 4 Director 23 May 2024, 17:15
EBS Emergent BioSolutions Inc. 25 May 2023 2 -$29.5K 4 Director 24 Jul 2023, 08:28
EBS Emergent BioSolutions Inc. 25 May 2023 1 $0 4 Director 30 May 2023, 19:09
EBS Emergent BioSolutions Inc. 09 Jun 2022 1 -$37K 4 Director 13 Jun 2022, 16:16
EBS Emergent BioSolutions Inc. 26 May 2022 1 $0 4 Director 31 May 2022, 16:13
EBS Emergent BioSolutions Inc. 24 May 2022 1 -$70.9K 4 Director 25 May 2022, 16:12
EBS Emergent BioSolutions Inc. 25 May 2021 1 -$177K 4 Director 27 May 2021, 16:37
EBS Emergent BioSolutions Inc. 20 May 2021 1 $0 4 Director 24 May 2021, 17:11